Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript

Page 6 of 6

So there’s a lot that I think the government is very proud of and Meiji is very proud of. CSL, certainly is excited to be supporting this program and launching it globally now. So there’s a lot of good news behind it. In terms of what is going to be a private pay versus government pay? Meiji you will make all those announcements when the time is right. But it’s something that we’re not really concerned about at this point.

Joe Payne : Yes. And the only thing I would add to that is that Meiji has a strong track record with working with the government to help with these subsidized vaccines in the flu space. So they’ve been doing this for years, and we’re working with the ideal partner, that’s done this before. All right.

Operator: We have reached the end of the question-and-answer session. I would now like to turn the call back over to Joe Payne for closing comments.

Joe Payne : Yes. Thanks, everyone, for participating on the call. And if there’s any remaining questions, don’t hesitate, as always, to reach out to the team. We’ll get back to you as soon as we can. All right. Thanks, everyone. Good night.

Operator: This concludes today’s conference. You may disconnect your lines at this time. And we thank you for your participation.

Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)

Page 6 of 6